This invention belongs to the field of
medicinal chemistry and relates to an antitumor compound. Specifically, this invention provides an antitumor compound of Formula I or a pharmaceutically acceptable salt, stereoisomer,
tautomer, polymorph, solvate, racemate,
prodrug, or
metabolite thereof, which exhibits good
antitumor activity.